A randomized, controlled trial of aprotinin in neonates undergoing open-heart surgery

Paediatric Anaesthesia

Volumn 18, Issue 9, 2008, Pages 812-819

  Williams, Glyn D ^a,b   Ramamoorthy, Chandra ^a   Pentcheva, Krassimira ^a   Boltz, M Gail ^a   Kamra, Komal ^a   Reddy, V Mohan ^a  

^a STANFORD UNIVERSITY   (United States)

^b M/C 5640 ^*  (United States)

Author keywords

Aprotinin; Cardiopulmonary bypass; Heart surgery; Infant: newborn; Randomized controlled trial

Indexed keywords

APROTININ; CREATININE; PLACEBO; SODIUM CHLORIDE;

ANESTHESIA; ARTICLE; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FOOD AND DRUG ADMINISTRATION; HEMOSTASIS; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LOADING DRUG DOSE; MALE; MORTALITY; NEWBORN; OPEN HEART SURGERY; OUTCOME ASSESSMENT; PEROPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; THROMBOSIS; TUBE; UNITED STATES;

ANALYSIS OF VARIANCE; APROTININ; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CREATININE; DOUBLE-BLIND METHOD; DRUG MONITORING; FEMALE; HEMOSTATICS; HOSPITAL MORTALITY; HUMANS; INFANT, NEWBORN; MALE; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; TREATMENT OUTCOME;

EID: 48249146197     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2008.02678.x     Document Type: Article

References (30)

1. US Food and Drug Administration. Drugs@FDA, http://www.accessdata.fda. gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search. Label_ApprovalHistory#apphist (accessed March 11, 2008).
2. Brown JR, Birkmeyer NJO, O'Connor GT. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation 2007 115 : 2801 2813.
3. Codispoti M, Mankad PS. Management of anticoagulation and its reversal during paediatric cardiopulmonary bypass: a review of current UK practice. Perfusion 2000 15 : 191 201.
4. Costello JM, Backer CL, Hoyos A et al. Aprotinin reduces operative closure time and blood product use after pediatric bypass. Ann Thorac Surg 2003 75 : 1261 1266.
5. D'Errico CC, Shayevitz JR, Martindale SJ et al. The efficacy and cost of aprotinin in children undergoing reoperative open heart surgery. Anesth Analg 1996 83 : 1193 1199.
6. Miller BE, Tosone SR, Tam VK et al. Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. Ann Thorac Surg 1998 66 : 535 540.
7. Mossinger H, Dietrich W, Braun SL et al. High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery. Ann Thorac Surg 2003 75 : 430 437.
8. Arnold DM, Fergusson DA, Chan AK et al. Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. Anesth Analg 2006 102 : 731 737.
9. Davies MJ, Alison A, Kort H et al. Prospective randomized double blind study of high dose aprotinin in pediatric cardiac operations. Ann Thorac Surg 1997 63 : 497 503.
10. Boldt J, Knothe C, Zickmann B et al. Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss. J Thorac Cardiovasc Surg 1993 105 : 705 711.
11. Carrel TP, Schwanda M, Vogt PR et al. Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only. Ann Thorac Surg 1998 66 : 153 158.
12. Tweddell JS, Hoffman GM, Mussatto KA et al. Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: lessons learned from 115 consecutive patients. Circulation 2002 106 : 82 89.
13. McEvoy MD, Reeves ST, Reves JG et al. Aprotinin in cardiac surgery: a review of conventional and novel mechanisms of action. Anesth Analg 2007 105 : 949 962.
14. Mangano DT, Tudor IC, Dietzel C et al. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006 354 : 353 365.
15. Karkouti K, Beattie WS, Dattilo KM et al. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. Transfusion 2006 46 : 327 338.
16. US Food and Drug Administration. http://www.fda.gov/bbs/topics/NEWS/2006/ NEW01529.html (accessed March 11, 2008).
17. US Food and Drug Administration. http://www.fda.gov/cder/drug/early_comm/ aprotinin.htm (accessed March 11, 2008).
18. Fergusson DA, Hébert PC, Mazer CD et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008 358 : 2319 2331.
19. Mangano DT, Miao Y, Vuylsteke A et al. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 2007 297 : 471 479.
20. Williams GD, Bratton SL, Ramamoorthy C. Factors associated with blood loss and blood product transfusions: a multivariate analysis in children after open-heart surgery. Anesth Analg 1999 89 : 57 64.
21. Bulutcu FS, Ozbek U, Polat B et al. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination? Pediatr Anesth 2005 15 : 41 46.
22. Chauhan S, Kumar BS, Rao BH et al. Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. Ann Thorac Surg 2000 70 : 1308 1312.
23. Baker MJ, Evans FM, Fazlollah T et al. Aprotinin is not an Independent Predictor of Post-operative Renal Dysfunction in Neonates Undergoing the Norwood Procedure. San Diego, CA : Society of Pediatric Anesthesia Meeting, April 3-6, 2008 (Abstract #3-4).
24. Dietrich W, Ebell A, Busley R et al. Aprotinin and anaphylaxis: analysis of 12,403 exposures to aprotinin in cardiac surgery. Ann Thorac Surg 2007 84 : 1144 1150.
25. Jacquiss RD, Ghanayem NS, Zacharisen MC et al. Safety of aprotinin use and re-use in pediatric cardiothoracic surgery. Circulation 2002 106 : 90 94.
26. Backer CL, Kelle AM, Stewart RD et al. Aprotinin is safe in pediatric patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2007 134 : 1421 1428.
27. Wagener G, Gubitosa G, Wang S et al. Increased incidence of acute kidney injury with aprotinin use during cardiac surgery detected with urinary NGAL. Am J Nephrol 2008 28 : 576 582.
28. Szédely A, Sápi E, Breuer T et al. Aprotinin and renal dysfunction after pediatric cardiac surgery. Pediatr Anesth 2008 18 : 151 159.
29. Chiravuri SD, Voepel-Lewis T, Devaney EJ et al. The use of aprotinin in children undergoing operative repair of isolated atrial septal defects. Pediatr Anesth 2008 18 : 145 150.
30. Chauhan S, Sanbhu N, Bisoi A et al. Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. J Cardiothorac Vasc Anesth 2004 18 : 141 143.